FDA Regulatory 2021 - The Veterinary Drug Approval Process and FDA Regulatory Oversight Training
Topics/Call fo Papers
This two-day interactive seminar online will provide attendees with an understanding of FDA’s veterinary drug approval process in 2021. The U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) is responsible for the approval of veterinary drug products intended for family pets, food-producing animals, and other animal species.
The group size is small, generally between 8 and 10 people, with plenty of opportunities to ask questions and discuss issues or challenges that the attendees have experienced.
How the U.S. Food and Drug Administration (FDA) regulates animal drug products.
How FDA’s Center for Veterinary Medicine is organized.
The process by which veterinary drug products are reviewed and approved.
Speaker:
Karl focuses his practice in FDA Regulatory law, representing U.S. and international clients in the food and drug industries with regard to pharmaceuticals and OTC drugs
The group size is small, generally between 8 and 10 people, with plenty of opportunities to ask questions and discuss issues or challenges that the attendees have experienced.
How the U.S. Food and Drug Administration (FDA) regulates animal drug products.
How FDA’s Center for Veterinary Medicine is organized.
The process by which veterinary drug products are reviewed and approved.
Speaker:
Karl focuses his practice in FDA Regulatory law, representing U.S. and international clients in the food and drug industries with regard to pharmaceuticals and OTC drugs
Other CFPs
- 2021 International Conference on Control and Intelligent Robots (ICCIR 2021)
- Design History Files and Technical Files/Design Dossiers - Meeting U.S. FDA CGMPS and the EU's MDD Requirements
- Excel Spreadsheets; Ensuring Data Integrity and 21 CFR Part 11 Compliance
- CGMP controlled Raw Materials
- PV (Pharmacovigilance) Audit Strategy Planning - A Practical Approach to Design and Implementation
Last modified: 2021-04-21 13:04:38